#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Thalassaemia beta Focal segmental glomerulosclerosis Soft tissue sarcoma Solitary fibrous tumour Chemical burn Richter's syndrome NTRK gene fusion overexpression Frostbite Bronchopulmonary dysplasia Synovial sarcoma recurrent Fragile X syndrome Homocystinuria Craniocerebral injury Heart disease congenital Thymic carcinoma More trials…

    Learn about Rare Diseases

    Mantle cell lymphoma stage II Osteosarcoma – Life with Disease Hereditary motor and sensory neuropathy Osteosarcoma metastatic – Basic Information Small intestine leiomyosarcoma – Trials in Disease Breast angiosarcoma – Diagnostics Primary hyperoxaluria – Life with Disease Wolfram syndrome – Diagnostics Encephalitis autoimmune – Diagnostics Mantle cell lymphoma – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Jk08 Mercaptopurine Pelareorep Vimseltinib Ziclumeran Other Blood Products Aldesleukin Tafasitamab SOFTISAN 378 Baloxavir Marboxil Spesolimab POTASSIUM HYDROXIDE Lacutamab Apocynin Diroximel Fumarate GSKVX000000039711 Dotatate Tolcapone Oxybuprocaine CAL101 More therapies…

    Learn about Your Condition

    Metabolic disorder Notalgia paraesthetica Type IIa hyperlipidaemia Neuroendocrine carcinoma Perthes disease Fibromyalgia Incisional hernia Vertebrobasilar stroke Hepatic cancer Plasma cell leukaemia Eosinophilic oesophagitis Mitral valve prolapse Pemphigus Breast angiosarcoma metastatic Malignant melanoma stage IV More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Testing a Drug Combination for Personalized Sepsis Treatment in Children and Adults with Severe Blood Infection

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Fludrocortisone Acetate
    • Heparin
    • Human Plasma Protein
    France

  • A Study Comparing GDC-4198 Alone and with Giredestrant versus Abemaciclib with Giredestrant for Advanced Breast Cancer After Previous CDK4/6 Treatment

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Human epidermal growth factor receptor negative
    • Hormone receptor positive breast cancer
    • Breast cancer
    Investigated Drugs:
    • Giredestrant
    • Abemaciclib
    France Germany Italy Spain

  • Long-Term Safety Study of Direclidine in Adults with Schizophrenia

    Recruiting

    3 1 1
    Investigated Diseases:
    • Schizophrenia
    Bulgaria Hungary Romania

  • A Study Comparing PF-08046054 to Docetaxel in Adults with Previously Treated PD-L1 Positive Non-Small Cell Lung Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • HUMANISED IGG1 MONOCLONAL ANTIBODY AGAINST PD-L1 CONJUGATED TO MONOMETHYL AURISTATIN E VIA A VALINE-CITRULLINE LINKER
    • Docetaxel
    Belgium Bulgaria Czechia Denmark Finland France +8

  • Study of AEF0217 compared to placebo for improving behavior and thinking skills in adults and older adolescents with Down syndrome

    Recruiting

    2 1
    Investigated Drugs:
    • 1-((3S,8S,9S,10R,13S,14S,17S)3-BENZYLOXY-10,13,17-TRIMETHYL-2,3,4,7,8,9,10,11,12,13,14,15,16,17-TETRADECAHYDRO-1HCYCLOPENTA[A]PHENANTHRENE-17-YL)ETHAN-1-ONE
    France Italy Spain

  • A study testing RO7790121 for moderate to severe rheumatoid arthritis in patients who did not respond to or cannot tolerate TNF or JAK inhibitor treatments

    Recruiting

    2 1
    Investigated Drugs:
    • Ro7790121
    Belgium Denmark France Germany Italy Poland +1
Previous Page
1 … 98 99 100 101 102 … 1,646
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!